Zobrazeno 1 - 10
of 297
pro vyhledávání: '"L, Pecen"'
Autor:
P Ameri, R B Schnabel, L Pecen, I Diemberger, M Gwechenberger, J Siller-Matula, P Kirchhof, R De Caterina
Publikováno v:
European Heart Journal. 43
Background Heart failure (HF) is an established risk factor for stroke and systemic embolic events (SEE) in subjects with atrial fibrillation (AF), but it is debated whether this risk varies according to left ventricular ejection fraction (LVEF). Met
Publikováno v:
European Heart Journal. 43
Background/Introduction Concomitant diabetes mellitus (DM) in patients with atrial fibrillation (AF) has been associated with a higher risk of stroke/systemic embolic events (SEE), and higher mortality. Purpose To evaluate effectiveness and safety ou
Autor:
J Siller-Matula, M Unverdorben, C C Wang, Y Koretsune, L Pecen, A Borrow, C Chen, P Kirchhof, R De Caterina
Publikováno v:
European Heart Journal. 43
Background Heart failure (HF) occurs in approximately 26% of patients with atrial fibrillation (AF). Real-world data of oral anticoagulation with edoxaban in AF patients with HF history are limited. Purpose To compare edoxaban effectiveness and safet
Autor:
R De Caterina, M Unverdorben, B C Lee, T Yamashita, W S Lin, C C Wang, L Pecen, A Borrow, C Chen, P Kirchhof
Publikováno v:
European Heart Journal. 43
Background Atrial fibrillation (AF) patients with a history of ischaemic stroke (IS) have a higher risk for recurrent IS events and were largely excluded from the pivotal, randomised, controlled phase 3 trials on oral anticoagulants. Thus, the effect
Autor:
T A C De Vries, L Pecen, J J Komen, I Diemberger, S Fumagalli, J R De Groot, P Kirchhof, R De Caterina
Publikováno v:
European Heart Journal. 43
Background/Introduction Many clinicians estimate the frailty of patients solely using their clinical expertise instead of validated scores. Previous reports show that women are more often perceived as frail than men. It is uncertain whether the same
Autor:
V Russo, C C Wang, M Unverdorben, T Yamashita, L Pecen, A Borrow, C Chen, P Kirchhof, R De Caterina
Publikováno v:
European Heart Journal. 43
Background Atrial fibrillation patients with a history of major bleeding (MB) are at high risk of future bleeding events; this history was an exclusion criterion in pivotal phase 3 trials of anticoagulation for stroke prevention. Real-world edoxaban
Autor:
S.P. Gampenrieder, V. Dezentjé, M. Lambertini, A. de Nonneville, M. Marhold, F. Le Du, A. Cortés Salgado, D. Alpuim Costa, M. Vaz Batista, N. Chic Ruché, C. Tinchon, A. Petzer, E. Blondeaux, L. Del Mastro, G. Targato, F. Bertucci, A. Gonçalves, F. Viret, R. Bartsch, C. Mannsbart, A. Deleuze, L. Robert, C. Saavedra Serrano, M. Gion Cortés, M. Sampaio-Alves, M. Vitorino, L. Pecen, C. Singer, N. Harbeck, G. Rinnerthaler, R. Greil, Marija Balic, Sonja Heibl, August Felix Zabernigg, Daniel Egle, Margit Sandholzer, Florian Roitner, Johannes Andel, Petra Pichler, Christopher Hager, Michael Knauer, Michael Hubalek, Claudia Bighin, Michelino De Laurentiis, Sabino De Placido, Fabio Puglisi, Luca Boni, Amelie de Gregorio, Tom Degenhardt, Luigi Formisano, Karin Beelen, Timothy Robinson, Amanda Fitzpatrick, Veronique Dieras, Volkmar Muller, Alessandra Gennari, Sabine Linn, Sofia Braga, Javier Cortes, Carlo Palmieri
Publikováno v:
ESMO open. 8(1)
Funding Information: This project was initiated at the Endeavour Breast Project coordinated by Daiichi Sankyo (special thanks to Christian Opitz and Britta Mazur from Daiichi Sankyo). We thank all participants and the steering committee members of th
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
D Morrone, C Chen, L Dinshaw, W Jiang, Y.-H Kim, P Kirchhof, Y Koretsune, L Pecen, P.-E Reimitz, C.-C Wang, T Yamashita, M Unverdorben, R De Caterina
Publikováno v:
European Heart Journal. 42
Background The ESC atrial fibrillation management guidelines recommend a risk-based approach to oral anticoagulant (OAC) therapy. How clinical practice aligns with these recommendations is of interest. Purpose To analyse real world data from Global E